AndrewMatthewFarlandMD

PubMed

• Transplanting FVIII/ET3-secreting cells in fetal sheep increases FVIII levels long-term without inducing immunity or toxicity.
  Martin Rodriguez, Brady Trevisan, Ritu M Ramamurthy, Sunil K George, Jonathan Diaz, Jordan Alexander, Diane Meares, Denise J Schwahn, David R Quilici, Jorge Figueroa, ...> ;Nature Communications. 2023 Jul 14
• 2 citations
  Comparison of different gene addition strategies to modify placental derived-mesenchymal stromal cells to produce FVIII.
  Ritu M Ramamurthy, Martin Rodriguez, Hannah C Ainsworth, Jordan Shields, Diane Meares, Colin Bishop, Andrew Farland, Carl D Langefeld, Anthony Atala, Christopher B Doe...> ;Frontiers in Immunology. 2022 Jan 1
• 5 citations
  Implementation of Individualized Pain Care Plans Decreases Length of Stay and Hospital Admission Rates for High Utilizing Adults with Sickle Cell Disease
  Jena L Welch-Coltrane, Anthony A Wachnik, Meredith C.B. Adams, Cherie R Avants, Howard Blumstein, Amber K Brooks, Andrew M. Farland, Joshua B Johnson, Manoj Pariyadath...> ;Pain Medicine. 2021 Aug 6
• 4 citations
  Investigating Optimal Autologous Cellular Platforms for Prenatal or Perinatal Factor VIII Delivery to Treat Hemophilia A.
  Christopher Stem, Christopher Rodman, Ritu M Ramamurthy, Sunil George, Diane Meares, Andrew M. Farland, Anthony Atala, Christopher B. Doering, H. Trent Spencer, Christ...> ;Frontiers in Cell and Developmental Biology. 2021 Aug 10
• 3 citations
  Effects of Shear Stress on Production of FVIII and vWF in a Cell-Based Therapeutic for Hemophilia A.
  Brady Trevisan, Alshaimaa Morsi, Julio Aleman, Martin Rodriguez, Jordan E Shields, Diane Meares, Andrew M. Farland, Christopher B. Doering, H. Trent Spencer, Anthony A...> ;Frontiers in Bioengineering and Biotechnology. 2021 Mar 1
• 9 citations
  Defining the Optimal FVIII Transgene for Placental Cell-Based Gene Therapy to Treat Hemophilia A
  Nadia El-Akabawy, Martin Rodriguez, Ritu M Ramamurthy, Andrew Rabah, Brady Trevisan, Alshaimaa Morsi, Sunil George, Jordan E Shields, Diane Meares, Andrew M. Farland, ...> ;Molecular Therapy. Methods & Clinical Development. 2020 Jun 12
• 5 citations
  Acute Thrombotic Microangiopathy and Cortical Necrosis Following Administration of Alemtuzumab: A Case Report.
  Ashley A. Liou, Brent M. Skiver, Eric Yates, Paul Persad, David Meyer, Andrew M. Farland, Michael V. Rocco> ;American Journal of Kidney Diseases. 2019 May 1
• Correlating S100B with disease course in a case of new onset, acquired thrombotic thrombocytopenic purpura (TTP): Could this be a new predictive biomarker in TTP?
  Patrick Kuhlman, Peter J. Miller, Andrew M. Farland, John Owen, Katharine Batt> ;Journal of Clinical Apheresis. 2018 Aug 1
• 20 citations
  Successful treatment of intravenously abused oral Opana ER‐induced thrombotic microangiopathy without plasma exchange
  Peter J. Miller, Andrew M. Farland, Mary Ann Knovich, Katharine Batt, John Owen> ;American Journal of Hematology. 2014 Jul 1
• 9 citations
  Long‐term management of acquired thrombotic thrombocytopenic purpura using serial plasma ADAMTS13 measurements
  Mary Ann Knovich, Andrew M. Farland, John Owen> ;European Journal of Haematology. 2012 Jun 1
• Join now to see all

Abstracts/Posters

• African American Race Is Associated with Decreased Relapse-Free Survival in Immune Thrombotic Thrombocytopenic Purpura
  Andrew M. Farland, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Differential Effect of Rituximab on Relapse-Free Survival in De Novo and Relapsed Immune Thrombotic Thrombocytopenic Purpura in African-American and Caucasian Populations
  Andrew M. Farland, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019